Literature DB >> 2705839

Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa.

B L Ungar1, M Mulligan, T B Nutman.   

Abstract

To obtain prevalence data on Cryptosporidium infection in healthy US adults and to determine how often Cryptosporidium infection occurs after relocation to a situation of potentially great exposure, an enzyme-linked immunosorbent assay for anti-Cryptosporidium IgM or IgG was used to examine serum from 75 US Peace Corps volunteers before overseas service and after up to two years in West Africa. Of the volunteers, 32% had detectable anti-Cryptosporidium IgG initially, suggesting that infection sometime in life is common. After six weeks, one year, or two years overseas, 5% (1/19), 14% (8/56), and 13.6% (3/22), respectively, became newly IgG positive. This implies that the risk of acquiring Cryptosporidium infection and its associated diarrhea is real for travelers and temporary workers in endemic areas. Persistence of IgG and/or IgM response for 12 months or more occurred in some volunteers, although the significance is unclear.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705839

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Serological responses to Cryptosporidium infection.

Authors:  T B Muller; F J Frost; G F Craun; R L Calderon
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Epidemiological aspects of human cryptosporidiosis.

Authors:  D P Casemore
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

3.  Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiency.

Authors:  T L Kuhls; S L Orlicek; D A Mosier; D L Crawford; V L Abrams; R A Greenfield
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Prevalence of infection with Cryptosporidium parvum and Cyclospora cayetanensis among international travellers.

Authors:  T Jelinek; M Lotze; S Eichenlaub; T Löscher; H D Nothdurft
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

5.  Cryptosporidium muris: infectivity and illness in healthy adult volunteers.

Authors:  Cynthia L Chappell; Pablo C Okhuysen; Rebecca C Langer-Curry; Philip J Lupo; Giovanni Widmer; Saul Tzipori
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

6.  Incorporation of exogenous uracil by Cryptosporidium parvum in vitro.

Authors:  S J Upton; M Tilley; R R Mitschler; B S Oppert
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Serological evidence of Cryptosporidium infections in southern Europe.

Authors:  F J Frost; E Fea; G Gilli; F Biorci; T M Muller; G F Craun; R L Calderon
Journal:  Eur J Epidemiol       Date:  2000-04       Impact factor: 8.082

8.  Longitudinal analysis of cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children.

Authors:  Jeffrey W Priest; Caryn Bern; Lihua Xiao; Jacquelin M Roberts; James P Kwon; Andres G Lescano; William Checkley; Lilia Cabrera; Delynn M Moss; Michael J Arrowood; Charles R Sterling; Robert H Gilman; Patrick J Lammie
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 9.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

Review 10.  Cryptosporidium and cryptosporidiosis: the African perspective.

Authors:  Hebatalla M Aldeyarbi; Nadia M T Abu El-Ezz; Panagiotis Karanis
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-29       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.